Khaldoun S. Abdelwahed

Pseurotin A as a novel suppressor of hormone dependent breast cancer progression and recurrence by inhibiting PCSK9 secretion and interaction with LDL receptor

Khaldoun S. Abdelwahed, Abu Bakar Siddique, Mohamed M. Mohyeldin et al. · Pharmacological Research · 2020 · 82 citations · Full text

Medicine, Cancer Biology, Oncology +14

HER2 Kinase-Targeted Breast Cancer Therapy: Design, Synthesis, and <i>In Vitro</i> and <i>In Vivo</i> Evaluation of Novel Lapatinib Congeners as Selective and Potent HER2 Inhibitors with Favorable Metabolic Stability

Tamer A. Elwaie, Safinaz E. Abbas, Enayat Ibrahim Aly et al. · Journal of Medicinal Chemistry · 2020 · 37 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Oleocanthal Attenuates Metastatic Castration-Resistant Prostate Cancer Progression and Recurrence by Targeting SMYD2

Abu Bakar Siddique, Hassan Y. Ebrahim, Afsana Tajmim et al. · Cancers · 2022 · 25 citations · Full text

Medicine, Oncology, Pharmacology +17

PCSK9 Axis-Targeting Pseurotin A as a Novel Prostate Cancer Recurrence Suppressor Lead

Khaldoun S. Abdelwahed, Abu Bakar Siddique, Mohammed H. Qusa et al. · ACS Pharmacology & Translational Science · 2021 · 22 citations · Full text

Medicine, Molecular Biology, Oncology +12

(-)-Oleocanthal Nutraceuticals for Alzheimer’s Disease Amyloid Pathology: Novel Oral Formulations, Therapeutic, and Molecular Insights in 5xFAD Transgenic Mice Model

Afsana Tajmim, Areli K. Cuevas-Ocampo, Abu Bakar Siddique et al. · Nutrients · 2021 · 19 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17